Optimizing patient selection and reducing heavy clinical burdens during drug development requires advanced predictive tools that can reliably replace traditional, time-consuming human studies. Certara software expertly addresses these critical challenges through its industry-leading Simcyp physiologically-based pharmacokinetic modeling platform, empowering researchers to make highly confident development decisions. By successfully predicting drug-drug interactions, food effects, and hepatic impairment impacts, the system allows sponsors to secure vital regulatory biowaivers and streamline submissions. Ultimately, Certara helps biopharmaceutical organizations accelerate drug pipelines, minimize unnecessary clinical trials, and bring safer, highly effective therapeutic treatments to patients

Join for free to read